Showing results (141-150 of 202) with videos related to
Sort By:
Pageof 21
Molecular Cancer Therapeutics|February 2, 2013
A human single-domain antibody elicits potent antitumor activity by targeting an epitope in mesothelin close to the cancer cell surfaceZhewei Tang, Mingqian Feng, Wei Gao, et al.Journal of Translational Medicine|August 5, 2020
32A9, a novel human antibody for designing an immunotoxin and CAR-T cells against glypican-3 in hepatocellular carcinomaXiaoyu Liu, Fang Gao, Longwei Jiang, et al.Kidney & Blood Pressure Research|December 12, 2017
High Phosphate-Induced Calcification of Vascular Smooth Muscle Cells is Associated with the TLR4/NF-κb Signaling PathwayDaohai Zhang, Xianjin Bi, Yong Liu, et al.EMBO Molecular Medicine|June 8, 2021
Targeting the SHP2 phosphatase promotes vascular damage and inhibition of tumor growthYuyi Wang, Ombretta Salvucci, Hidetaka Ohnuki, et al.Oncogene|February 26, 2004
LFIRE-1/HFREP-1, a liver-specific gene, is frequently downregulated and has growth suppressor activity in hepatocellular carcinomaJun Yan, Yanlin Yu, Nan Wang, et al.Nature Medicine|October 9, 2002
Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesisRichard Sharp, Juan A Recio, Chamelli Jhappan, et al.Journal of Molecular Medicine (Berlin, Germany)|May 17, 2017
DNA hypermethylation of sFRP5 contributes to indoxyl sulfate-induced renal fibrosisYanlin Yu, Xu Guan, Ling Nie, et al.Bioconjugate Chemistry|August 22, 2024
Sortase-Mediated Site-Specific Conjugation to Prepare Fluorine-18-Labeled NanobodiesFalguni Basuli, Jianfeng Shi, Eric Lindberg, et al.Molecular Cancer Therapeutics|May 2, 2022
Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid TumorsSakshi Tomar, Jingli Zhang, Manakamana Khanal, et al.Biorxiv : the Preprint Server for Biology|May 7, 2026
Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid TumorsMingyu Huo, Dan Li, Nan Li, et al.Pageof 21